@vfrioni
couldn't agree more, with everything going against the company (slow decision making, DSA disaster) the company posted a very impressive result
given revenue of 28,413K their NPBT was 6,260K...that's 22%!!!!
extrapolating for another month and adding the company's prediction of 65% increased revenues for the last 5 months we should end up with approximately 72,220k in revenues or 15,888 NPBT or say 11,121K NPAT (assuming full 30% tax rate)
at market cap of 106m this is a pretty undemanding PE of 9.5x
the contracts worth of 40m the company is bidding for can only surprise
i have a feeling the company is turning around and could be vulnerable to someone bigger looking at adding dewatering business
cheers
- Forums
- ASX - By Stock
- RQL
- interim results are out
interim results are out, page-5
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RQL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online